Telix Pharmaceuticals Limited · ASX:TLX
Smith Darren Charlton bought 2,071 Telix Pharmaceuticals Limited shares (Form 4)
Traded Sep 7, 2026 · Filed Sep 14, 2026
On Sep 7, 2026, Smith Darren Charlton (Group Chief Financial Officer) bought 2,071 Telix Pharmaceuticals Limited shares at US$9.66 for US$20,006, leaving 13,992 shares. Filed Sep 14, 2026 (Form 4).
- Bought
- 2,071 shares
- Price
- US$9.66
- Value
- US$20,006
- Holding after
- 13,992 shares
- Trading plan
- No
- Role
- Group Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 7, 2026 | Ordinary Shares | Buy | 2,071 | US$9.66 | 13,992 | Direct |